SPAC1F3.05 Antibody

What is SPAC1F3.05 and why is it studied in molecular biology research?

SPAC1F3.05 is a gene in the fission yeast Schizosaccharomyces pombe (strain 972/ATCC 24843) that encodes a probable ADP-ribosylation factor-binding protein . This protein has been identified as a TOM1-like protein 2 that may play a role in the regulation of membrane traffic through the trans-Golgi network .

S. pombe has emerged as a valuable model organism because it shares more features with humans than S. cerevisiae (budding yeast), including gene structures, chromatin dynamics, prevalence of introns, and control of gene expression through pre-mRNA splicing, epigenetic gene silencing, and RNAi pathways . Therefore, studying SPAC1F3.05 contributes to our understanding of conserved cellular mechanisms.

What are the specifications of commercially available SPAC1F3.05 antibodies?

The commercially available SPAC1F3.05 antibody has the following specifications:

This information is essential for researchers to determine if the antibody is suitable for their experimental needs and to properly handle the reagent .

How should SPAC1F3.05 antibody be validated for specificity in S. pombe research?

Validating antibody specificity is crucial for reliable research outcomes. For SPAC1F3.05 antibody, a comprehensive validation approach should include:

• Knockout/deletion strain comparison: Generate or obtain a SPAC1F3.05 gene deletion strain from the S. pombe genome deletion collection, which now covers 99% of fission yeast open reading frames . Compare Western blot signals between wild-type and deletion strains.

• Overexpression controls: Express recombinant SPAC1F3.05 with an orthogonal tag (e.g., FLAG or GFP) and demonstrate co-localization or co-detection with the SPAC1F3.05 antibody.

• Cross-reactivity assessment: Test the antibody against closely related proteins or in other yeast species to confirm specificity.

• Multiple detection methods: Validate using both Western blot and immunoprecipitation, as performed in the SMOC-1 antibody characterization study that employed standardized protocols and knockout controls .

The recent YCharOS antibody characterization platform approach could serve as a model, which compares signals in knockout cell lines and isogenic parental controls using standardized experimental protocols .

What are the optimal conditions for Western blot detection of SPAC1F3.05?

Based on the antibody specifications and research on similar yeast proteins:

• Sample preparation:

  • Harvest S. pombe cells in logarithmic growth phase

  • Extract proteins using glass bead lysis in buffer containing protease inhibitors

  • Include phosphatase inhibitors if studying phosphorylation states

• Gel electrophoresis and transfer:

  • 10-12% SDS-PAGE gels recommended for optimal separation

  • Transfer to PVDF membranes at 100V for 60 minutes in cold transfer buffer

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Incubate with SPAC1F3.05 antibody at 1:1000 dilution overnight at 4°C

  • Wash extensively with TBST (4 × 5 minutes)

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour

  • Develop using enhanced chemiluminescence

• Controls:

  • Include wild-type S. pombe lysate as positive control

  • Include SPAC1F3.05 deletion strain lysate as negative control

  • Include loading control (e.g., anti-tubulin)

These conditions should be optimized for each specific research application .

How can SPAC1F3.05 antibody be used in studying membrane trafficking pathways in S. pombe?

Given SPAC1F3.05's potential role in trans-Golgi network regulation, researchers can employ several advanced approaches:

• Subcellular co-localization studies:

  • Use SPAC1F3.05 antibody in immunofluorescence microscopy alongside markers for different cellular compartments (e.g., Golgi, endosomes)

  • Implement live-cell imaging with GFP-tagged versions to track dynamic localization

• Protein-protein interaction studies:

  • Employ immunoprecipitation with SPAC1F3.05 antibody followed by mass spectrometry to identify interacting partners

  • Verify interactions with co-immunoprecipitation and reverse co-immunoprecipitation

  • Use proximity labeling techniques (BioID or APEX) coupled with the antibody for in vivo interaction studies

• Functional perturbation analysis:

  • Compare vesicular trafficking dynamics in wild-type versus SPAC1F3.05 deletion strains

  • Use the antibody to deplete SPAC1F3.05 from cell extracts in in vitro reconstitution assays

  • Combine with small molecule inhibitors of trafficking to dissect pathway dependencies

This approach is similar to how researchers have used antibodies to study other conserved cellular pathways in model organisms .

Can SPAC1F3.05 antibody be used for epitope mapping and structural studies?

Yes, the SPAC1F3.05 antibody can be valuable for epitope mapping and structural studies:

• Epitope mapping techniques:

  • Generate truncated versions of the SPAC1F3.05 protein to determine the minimal binding region

  • Use peptide arrays with overlapping sequences to identify specific binding epitopes

  • Employ hydrogen-deuterium exchange mass spectrometry (HDX-MS) to identify protected regions upon antibody binding

• Structural applications:

  • Use the antibody to stabilize SPAC1F3.05 for crystallization trials

  • Employ cryo-electron microscopy of antibody-antigen complexes to determine binding interactions

  • Apply molecular docking methods similar to those used for the Abs-9 antibody against SpA5 to predict binding interfaces

• Validation approaches:

  • Confirm epitope predictions through site-directed mutagenesis of key residues

  • Use competitive binding assays with synthetic peptides corresponding to predicted epitopes

  • Apply deep sequencing of antibody-resistant variants to map functionally important epitopes

These approaches have been successfully applied in characterizing antibody-antigen interactions in various systems, including SARS-CoV-2 and S. aureus research .

How can researchers address cross-reactivity issues with SPAC1F3.05 antibody?

Cross-reactivity is a common challenge with antibodies. To address this with SPAC1F3.05 antibody:

• Systematic validation:

  • Test the antibody against lysates from deletion strains of related genes

  • Perform immunoblotting with recombinant proteins of related family members

  • Conduct peptide competition assays to confirm specificity

• Pre-adsorption techniques:

  • Pre-incubate the antibody with recombinant related proteins to remove cross-reactive antibodies

  • Use lysates from SPAC1F3.05 deletion strains to pre-adsorb non-specific antibodies

• Alternative detection strategies:

  • Consider using epitope-tagged versions of SPAC1F3.05 with highly specific commercial antibodies

  • Develop monoclonal antibodies with higher specificity using phage display methods similar to those used for ASP5 antibody generation

• Data interpretation:

  • Always include appropriate negative controls

  • Validate key findings with orthogonal methods that don't rely on the antibody

  • Consider mass spectrometry to confirm the identity of immunoprecipitated proteins

These approaches can help ensure reliable data interpretation despite potential cross-reactivity issues .

What strategies can improve signal detection when working with low-abundance SPAC1F3.05 protein?

Low protein abundance presents challenges for detection. Researchers can implement these strategies:

• Sample enrichment:

  • Concentrate protein extracts using TCA precipitation or acetone precipitation

  • Perform subcellular fractionation to enrich for Golgi/endosomal compartments where SPAC1F3.05 may be concentrated

  • Use immunoprecipitation to concentrate the protein before Western blotting

• Signal amplification methods:

  • Employ tyramide signal amplification (TSA) for immunofluorescence

  • Use high-sensitivity ECL substrates for Western blotting

  • Consider biotin-streptavidin amplification systems for detection

• Optimized protocols:

  • Reduce background by optimizing blocking conditions (test BSA vs. milk)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Optimize antibody concentration through titration experiments

  • Consider specialized detergents for membrane protein extraction if traditional methods yield poor results

• Alternative detection methods:

  • Consider RNA-level analysis (RT-qPCR) to complement protein studies

  • Use proximity ligation assay (PLA) for detecting protein-protein interactions with higher sensitivity

  • Consider mass spectrometry-based targeted proteomics for precise quantification

These approaches have proven effective in detecting low-abundance proteins in various experimental systems .

How does antibody detection of SPAC1F3.05 compare with gene deletion phenotype analysis?

Integrating antibody-based protein detection with gene deletion phenotype analysis provides complementary insights:

• Correlation analysis:

  • Protein levels detected by antibody may not directly correlate with phenotype severity

  • Post-translational modifications detected by specific antibodies may reveal regulatory mechanisms not apparent in deletion studies

  • Localization changes detected by immunofluorescence may explain conditional phenotypes

• Methodological complementarity:

  • Gene deletions in the S. pombe genome deletion project reveal complete loss-of-function phenotypes

  • Antibody-based approaches can reveal dosage-dependent effects, protein interactions, and localization

  • Combined approaches can distinguish between structural and catalytic roles of proteins

• Conditional analyses:

  • Use temperature-sensitive alleles and compare protein levels/localization (by antibody) with phenotype severity

  • Study environmental stress responses where protein modifications rather than expression levels may be critical

  • Examine cell cycle-dependent changes in protein abundance/localization versus function

• Data integration framework:

  Analysis Approach	Information Gained	Limitations	Complementary Methods
  Gene deletion	Complete loss-of-function phenotype	Cannot observe partial functions	Antibody detection of protein levels
  Antibody immunoblotting	Protein abundance, modifications	Cannot directly assess function	Functional assays with deletion strains
  Immunofluorescence	Protein localization	Limited resolution	Super-resolution microscopy, fractionation
  Co-immunoprecipitation	Protein interactions	May detect non-physiological interactions	In vivo crosslinking, proximity labeling

This integrated approach has proven valuable in characterizing gene functions in fission yeast .

What considerations are important when comparing SPAC1F3.05 detection across different experimental conditions?

When comparing SPAC1F3.05 detection across different conditions, researchers should consider:

• Technical considerations:

  • Ensure consistent protein extraction methods between samples

  • Include internal loading controls for normalization (e.g., tubulin, actin)

  • Process all samples simultaneously when possible to minimize batch effects

  • Consider the linear detection range of your detection method

• Biological variables:

  • Cell cycle stage can significantly affect protein levels and localization

  • Growth phase of yeast cultures (log versus stationary) impacts many cellular processes

  • Nutritional status affects numerous cellular pathways

  • Stress conditions may alter protein stability or epitope accessibility

• Quantification approaches:

  • Use digital imaging and analysis software for objective quantification

  • Apply appropriate statistical tests to determine significance of observed differences

  • Consider replicate experiments to account for biological variability

  • Use spike-in controls of recombinant protein for absolute quantification

• Validation strategies:

  • Confirm key findings with orthogonal methods

  • Use GFP-tagged versions for live cell imaging to complement fixed-cell antibody-based detection

  • Consider targeted proteomics approaches for precise quantification across conditions

These considerations reflect best practices in comparative analyses of protein abundance and localization in model organisms like S. pombe .

How can SPAC1F3.05 antibody be used in the context of systematic proteomics studies?

SPAC1F3.05 antibody can be integrated into systematic proteomics approaches:

• Immunoprecipitation-mass spectrometry (IP-MS):

  • Use the antibody to pull down SPAC1F3.05 and associated proteins

  • Analyze interaction partners under different conditions or cell cycle stages

  • Compare interactomes between wild-type and mutant versions of SPAC1F3.05

• Systematic co-immunoprecipitation studies:

  • Screen interactions with candidate partners identified from genetic screens

  • Validate high-throughput interaction data from yeast two-hybrid or proximity labeling studies

  • Map domain-specific interactions using truncated constructs

• Cross-species comparative analysis:

  • If the antibody cross-reacts with homologs in related species, compare protein interactions across evolutionary distance

  • Map conserved versus species-specific interactions to infer functional evolution

  • Use similar approaches to those used in public antibody response studies to identify conserved structural features

• Integration with genome-wide datasets:

  • Correlate protein abundance/localization data with transcriptome data

  • Integrate with phosphoproteomics to identify regulated interaction networks

  • Map protein interactions onto genetic interaction networks to identify functional modules

These approaches have been successfully applied in systematic studies of protein function in model organisms .

What role can SPAC1F3.05 antibody play in studying post-translational modifications?

The antibody can be crucial for studying post-translational modifications (PTMs) of SPAC1F3.05:

• Detecting native modifications:

  • Use the antibody to immunoprecipitate native SPAC1F3.05 for PTM analysis by mass spectrometry

  • Perform Western blots under conditions that preserve phosphorylation, ubiquitination, or other modifications

  • Use sequential immunoprecipitation to enrich for specific modified forms

• PTM-specific approaches:

  • Generate modification-specific antibodies against predicted sites

  • Use Phos-tag gels to separate phosphorylated from non-phosphorylated forms

  • Employ specific de-modifying enzymes (phosphatases, deubiquitinases) to confirm modification identity

• Functional studies of modifications:

  • Compare PTM patterns in wild-type versus mutant strains with altered phenotypes

  • Map modifications to specific functional domains of SPAC1F3.05

  • Use site-directed mutagenesis to create non-modifiable versions and assess functional consequences

• Spatiotemporal dynamics:

  • Examine cell cycle-dependent changes in modifications

  • Study stress-induced modification patterns

  • Investigate localization changes associated with specific modifications

Similar approaches have revealed important insights into protein regulation in various systems, including public antibody responses to antigens like SARS-CoV-2 spike protein .

How might single-cell analysis approaches incorporate SPAC1F3.05 antibody?

Emerging single-cell technologies offer new opportunities for antibody applications:

• Single-cell proteomics approaches:

  • Adapt mass cytometry (CyTOF) protocols to include SPAC1F3.05 antibody for single-cell protein quantification

  • Develop microfluidic antibody capture platforms for single-cell protein analysis

  • Employ single-cell Western blotting technologies to detect protein variability across individual cells

• Spatial proteomics integration:

  • Use SPAC1F3.05 antibody in imaging mass cytometry to maintain spatial context

  • Apply multiplexed ion beam imaging (MIBI) with the antibody for high-dimensional spatial analysis

  • Combine with multiplexed immunofluorescence to examine co-localization with multiple markers

• Single-cell functional approaches:

  • Correlate antibody-based protein detection with single-cell RNA-seq data

  • Integrate with microfluidic phenotyping to link protein levels to single-cell behaviors

  • Develop antibody-based sensors for live-cell tracking of SPAC1F3.05 dynamics

• Technical adaptations:

  • Optimize fixation and permeabilization protocols for single-cell applications

  • Validate antibody performance in single-cell contexts with appropriate controls

  • Consider nanobody or single-chain antibody formats for improved cellular penetration

These approaches mirror the high-throughput single-cell RNA and VDJ sequencing methods used in identifying antibodies against pathogens like S. aureus .

What computational approaches might enhance SPAC1F3.05 antibody-based research?

Advanced computational methods can significantly enhance antibody-based research:

• Structural prediction and epitope mapping:

  • Use AlphaFold2 to predict SPAC1F3.05 structure and potential epitopes

  • Apply molecular docking simulations to model antibody-antigen interactions

  • Employ deep learning approaches to predict optimal epitopes for new antibody development

• Image analysis automation:

  • Implement machine learning for automated quantification of immunofluorescence

  • Develop deep learning models for subcellular localization pattern recognition

  • Apply computer vision algorithms to track protein dynamics in live-cell imaging

• Integrative data analysis:

  • Develop computational pipelines to integrate antibody-derived data with other omics datasets

  • Apply network analysis algorithms to place SPAC1F3.05 in functional interaction networks

  • Use Bayesian approaches to infer causal relationships in perturbation experiments

• Predictive modeling:

  • Train machine learning models on antibody data to predict protein behavior under novel conditions

  • Develop systems biology models incorporating antibody-derived quantitative data

  • Apply deep learning to predict functional consequences of mutations based on antibody detection patterns